Keyword Connections

neuropsychiatrygeriatrics

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

36

1 γ-secretase-dependent proteolysis of transmembrane domain of amyloid precursor protein: successive tri- and tetrapeptide release in amyloid β-protein production

2 seeking a new paradigm for alzheimer’s disease: considering the roles of inflammation, blood-brain barrier dysfunction, and prion disease

3 a comparative study of five mouse models of alzheimer's disease: cell cycle events reveal new insights into neurons at risk for death

4 diagnostic tests for alzheimer's disease: rationale, methodology, and challenges

5 neuroprotection and neurodegeneration in alzheimer’s disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in african americans

6 mitochondria, cognitive impairment, and alzheimer's disease

7 brain functional network in alzheimer's disease: diagnostic markers for diagnosis and monitoring

8 on the involvement of copper binding to the n-terminus of the amyloid beta peptide of alzheimer's disease: a computational study on model systems

9 will posttranslational modifications of brain proteins provide novel serological markers for dementias?

10 enhancing resourcefulness to improve outcomes in family caregivers and persons with alzheimer’s disease: a pilot randomized trial

11 biomarkers in alzheimer's disease and lewy body disorders with dementia

12 conjugated quantum dots inhibit the amyloid β (1–42) fibrillation process

13 nonconvulsive seizures and dementia: a case report

14 chinese-language montreal cognitive assessment for cantonese or mandarin speakers: age, education, and gender effects

15 nanoscale extracellular vesicle analysis in alzheimer’s disease diagnosis and therapy

16 mitochondria are related to synaptic pathology in alzheimer's disease

17 behavioral impact of the regulation of the brain 2-oxoglutarate dehydrogenase complex by synthetic phosphonate analog of 2-oxoglutarate: implications into the role of the complex in neurodegenerative diseases

18 longitudinal changes in the government-certified index stage and requisite costs for long-term care insurance system among the community-dwelling demented elderly in japan

19 amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts

20 development and psychometric validation of the dementia attitudes scale

21 complex and multidimensional lipid raft alterations in a murine model of alzheimer's disease

22 alzheimer's disease and the amyloid cascade hypothesis: a critical review

23 the pathogenesis of alzheimer's disease: a reevaluation of the “amyloid cascade hypothesis”

24 melatonin in mitochondrial dysfunction and related disorders

25 neprilysin is poorly expressed in the prefrontal cortex of aged dogs with cognitive dysfunction syndrome

26 neuroprotection and neuroregeneration in alzheimer's disease

27 ocular manifestations of alzheimer’s disease in animal models

28 vaccine development to treat alzheimer’s disease neuropathology in app/ps1 transgenic mice

29 the alzheimer's amyloid-degrading peptidase, neprilysin: can we control it?

30 functional analytic multisensory environmental therapy for people with dementia

31 choline modulation of the aβ p1-40 channel reconstituted into a model lipid membrane

32 confounding factors influencing amyloid beta concentration in cerebrospinal fluid

33 the relationship between different assays for detection and quantification of amyloid beta 42 in human cerebrospinal fluid

34 the role of gsk3 in presynaptic function

35 aβ behavior on neuronal membranes: aggregation and toxicities

36 trends in prevalence and mortality of dementia in elderly hong kong population: projections, disease burden, and implications for long-term care